RSC-BMCS / SCI 23rd Medicinal Chemistry Symposium
Event
RSC-BMCS / SCI 23rd Medicinal Chemistry Symposium
Dates
Sunday – Wednesday, 14th-17th September, 2025
Place
Churchill College, Cambridge
Important links and downloads
X hashtag – #CamMedChem25
Synopsis
The organisers invite you to the 23rd SCI-RSC Medicinal Chemistry symposium, Europe’s premier biennial Medicinal Chemistry event, focusing on first disclosures and new strategies in Medicinal Chemistry.
Workshop
The workshop is based on an interactive, team-based game that allows you to explore various aspects of the drug discovery process. Delegates will work together in teams with peers from other organisations and the learning experience will be facilitated by a dedicated and diverse team of experienced professional medicinal chemists from across the pharmaceutical industry. This is a great way to accelerate your learning curve in medicinal chemistry, learning from your peers and our experts and it’s a lot of fun to play!
This event will be of interest to early career scientists, typically with five years or fewer post-graduate experience in medicinal chemistry.
Abstract submissions
Abstract submission is now open! If you would like to submit an abstract please click here.
The deadline for submission is Wednesday 30th April 2025.
Registration
Please click here to register.
Registration Packages:
| Residential Package Full conference attendance plus 3 Dinners & 3 Nights Accommodation |
Conference Attendance Only Does NOT include Conference Dinners or Accommodation |
|
| RSC/SCI Member* | £1010.00 | £510.00 |
| Non-member | £1130.00 | £630.00 |
| RSC/SCI Student** Member* (undergraduate and post-graduate) | £710.00 | £210.00 |
| Student** non-member (undergraduate and post-graduate) | £815.00 | £315.00 |
* Member is a paid-up member of the RSC / SCI
** Student rates apply to undergraduate and post-graduate students only, but not post-doctoral students.
***The Sunday BBQ, Monday Dinner, and Conference Dinner can be booked separately at an additional cost.
If you decide to choose the Conference Attendance Only package, this does not include dinners. If you would like to attend any of the dinners this is also available at a separate cost
Sunday Night BBQ: £40.00
Monday Night Churchill College Dinner: £70.00
Tuesday Night Conference Dinner: £95.00
Exhibition/Sponsorship opportunities
Do not miss the chance to exhibit at this popular meeting, please register here.
Confirmed Speakers:
Giueseppe Alvaro, Autifony Therapeutics- Inside Kv3.1 channel: The binding and the mechanism of positive modulators
Sharan Bagal, AstraZeneca- A novel androgen receptor proteolysis targeting chimera (AR-PROTAC) for the treatment of prostate cancer
Tim Barrett, GSK- Talk Title TBC
Alessio Cuilli, University of Dundee – New insights and twists on PROTAC and molecular glue degraders design and mechanism
Ed Griffen, Mechemica – New Pan-lethal Coronavirus antivirals for Pandemic Preparedness
Timo Heinrich, Merck Group – Merck’s TEAD endeavor: hit optimizations, selectivity considerations, CNS availability and MoA studies.
Andras Kotschy, Servier – Bcl-xL from inhibition to degradation: a quest for increased therapeutic index
Fionn O’Hara, F. Hoffmann-La Roche – Identification of a peripherally restricted MAGL inhibitor with potential to treat inflammatory bowel disease
Fabio Rancati, Chiesi – Discovery of CHF-6333: a Neutrophilic elastase inhibitor under clinical development
Candice Soares de Melo, H3D – Lead optimization of Thienopyrimidines as potential long acting antimalarials
Beth Thomas, Storm Therapeutics – Targeting Cancer with First-in-Class Inhibitors of the RNA m7G Methyltransferase METTL1
Petr Vachal, MSD- Invention of MK-0616, an Orally Bioavailable Macrocyclic Peptide PCSK9 Inhibitor
Michiel Van Gool, J&J Innovative Medicine – From Phenotypic Screening to a Preclinical Lead – the Discovery of JNJ-9676, a Small Molecule Sarbecovirus Inhibitor Targeting the Viral Membrane Protein
Naeem Yusuff, Astellas – Talk Title TBC
Exhibitors
Sponsors
Organising Committee
John Cumming, Roche
Mark Healy, Novartis
Daniel O Donovan, AstraZeneca
Joanne Pinder, Vertex
Jamie Scott, AstraZeneca
Gordon Saxty, NS-MC Consulting (Chair)
Chris Swain, Cambridge MedChem Consulting
Andrew Williams, Chairman of the RSC BMCS
Secretariat Contact and Further Information
Hg3 Conferences Ltd
+44 (0)1423 529333
events@hg3.co.uk
